U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Bizarre Patents

Patent No. 6637829

Decorative Jeweled Wheel Cover

An improved wheel is provided wherein decorative items such as gem stones are embedded in either the wheel surface, a special mounting section attached to the wheel surface, or to a spoke strap that wraps around each spoke and positions embedded gem stones on the outside surface of the spoke.

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Attorney: Hall; Robert C.


Number of patents: 118
Last date: April 24, 2012

1      
NumberTitleIssue Date
8163929Dihydropyridone amides as P2Xmodulators
Compounds of the formula I: or pharmaceutically acceptable salts thereof, wherein m, n, p, q, R1, R2, R3, R4, R5 and R6 are as defined herein. Also disclosed...
04/24/2012
8153809Dihydropyridone ureas as P2Xmodulators
Compounds of the formula I: or pharmaceutically acceptable salts thereof, wherein m, n, R1, R2, R3, R4 and R5 are as defined herein. Also disclosed are methods of makin...
04/10/2012
8153808Dihydropyridone amides as P2X7 modulators
Compounds of the formula I: or pharmaceutically acceptable salts thereof, wherein m, n, R1, R2, R3, R4 and R5 are as defined herein. Also disclosed are methods of makin...
04/10/2012
8119842Process for synthesis of amino-methyl tetralin derivatives
Methods for producing a compound of formula k1 or k2 by reducing a dihydronapthalene amide compound of formula i with hydrogen gas in the presence of a ruthenium catalyst of formu...
02/21/2012
8119644Thiadiazole-substituted arylamides as P2X3 and P2X2/3 antagonists
Compounds of the formula I: or a pharmaceutically acceptable salt thereof, wherein, R1 is optionally substituted thiadiazolyl, and R2, R3, R4, R5, R6, R...
02/21/2012
8101665Process for synthesis of tritiated and deuterated thiorphan and acetorphan
Methods for preparing tritium or deuterium labeled thiorphan comprising reacting a compound of formula j wherein m is from 1 to 5 and X is halo, with Z2 wherein Z is tritium or deuterium, in the presence of a cat...
01/24/2012
8093424Tetralin and indane derivatives and uses thereof
Compounds of the formula I: or pharmaceutically acceptable salts thereof, wherein m, p, q, Ar, R1 and R2 are as defined herein. Also provided are methods for preparing, compositions com...
01/10/2012
8093285Aminopiperidinyl derivatives and uses thereof
This application discloses aminopiperidinyl compounds of generic Formulae I-II: or pharmaceutically acceptable salts thereof, wherein m, r, Q1, Q2, Q3, R, Ra, R1, R
01/10/2012
8093275Oxazolone and pyrrolidinone-substituted pryidine amides as P2Xand P2Xantagonists
Compounds of the formula I: or a pharmaceutically acceptable salt thereof, wherein, X, Y, R1, R2, R3, R4, R5, R6 and R7 are as defined herein. Als...
01/10/2012
8084623Pyrrolidinyl and piperidinyl ketone derivatives and uses thereof
Compounds of the formula: or pharmaceutically acceptable salts thereof, wherein m, n, Ar, R1, R2, Ra and Rb are defined herein. Also provided are pharmaceutical composit...
12/27/2011
8048905Tetrazole-substituted arylamides as P2Xand P2Xantagonists
Compounds of the formula I: or a pharmaceutically acceptable salt thereof, wherein, R1 is optionally substituted tetrazolyl, R2 is optionally substituted phenyl, optionally substituted pyridinyl or opt...
11/01/2011
8008313Methods of using diaminopyrimidine P2Xand P2Xreceptor modulators for treatment of respiratory and gastrointestinal diseases
Methods for treating respiratory and gastrointestinal diseases mediated by a P2X3 and/or a P2X2/3 receptor antagonist, the methods comprising administering to a subject in need thereof an effective amount of a compound of formula (I):
08/30/2011
8003788Process for synthesis of phenoxy diaminopyrimidine derivatives
A method for preparing a compound of formula k or a salt or solvate thereof, wherein R1 is as defined herein, the method comprising treating a c...
08/23/2011
8003099Antibodies against human IL17 and uses thereof
An antibody binding to IL-17 characterized by binding to the same IL-17 epitope to which monoclonal antibody 3C1 binds, and being of human IgG1 isotype modified in the hinge region at amino acid position 216-240, preferably at amino acid position 220-240, between C
08/23/2011
7998963Arylpiperazine derivatives and uses thereof
Compounds of formula I: or pharmaceutically acceptable salts thereof, wherein Ar is indolyl, indazolyl or dihydroindolyl, and R1, R2, R3 and R4 are as defined herein. Also provide...
08/16/2011
7989637Triazole-substituted arylamides as P2Xand P2Xantagonists
Compounds of the formula I: or a pharmaceutically acceptable salt thereof, wherein, R1 is optionally substituted triazolyl, and R2, R3, R4, R5, R6, R7
08/02/2011
7981923Tetralin and indane derivatives and uses thereof
Compounds of the formula I, II or III: or pharmaceutically acceptable salts thereof, wherein m, n, q, Ar, R1, R2, R3, R4 and R5 are as defined herein. Also pr...
07/19/2011
7981914Tetrazole-substituted aryl amide derivatives and uses thereof
Compounds of the formula: wherein R1, R2, Ar1, Ar2, and n are as defined herein. Also provided are pharmaceutical compositions, methods of using, and methods of preparing the subj...
07/19/2011
7951920Conjugate of an antibody against CCR5 and an antifusogenic peptide
The current invention is related to a conjugate comprising one or more antifusogenic peptides and an anti-CCR5 antibody (mAb CCR5) characterized in that one to eight antifusogenic peptides are each conjugated to one terminus of the heavy and/or light chains of the a...
05/31/2011
7901901Assays for measuring phosphate modification enzyme activity
The present invention relates to assays that can measure the activity of enzymes that catalyze phosphate modifications, such as kinases, phosphatases, cyclases and phosphodiesterases. The assays can also be used to identify and screen for substances that modulate th...
03/08/2011
7868141Anti-OX40L antibodies
This invention relates to anti-OX40L antibodies and, in particular, to anti-OX40L antibodies and variants thereof that contain a Fc part derived from human origin and do not bind complement factor C1q. These antibodies have new and inventive properties causing a ben...
01/11/2011
78633053-amino-1-arylpropyl indoles as monoamine reuptake inhibitors
Compounds of formula I: or pharmaceutically acceptable salts, solvates or prodrugs thereof, wherein p, Ar, R1, R2, R3, Ra, Rb, Rc, Rd
01/04/2011
7858654Imidazole-substituted arylamides as P2Xand P2Xantagonists
Compounds of the formula I: wherein R1 is optionally substituted imidazolyl, and R2, R3, R4, R5, R6, R7 and R8 are as defined herein. A...
12/28/2010
7858632Diaminopyrimidines as P2Xand P2Xantagonists
Compounds and methods for treating diseases mediated by a P2X3 and/or a P2X2/3 receptor antagonist, the methods comprising administering to a subject in need thereof an effective amount of a compound of formula (I):
12/28/2010
78038303-amino-1-arylpropyl indoles and AZA-substituted indoles and uses thereof
The present invention provides compounds of the formula: or pharmaceutically acceptable salts, solvates or prodrugs thereof, wherein p, Ar, R1, R2, R3, Ra, Rb...
09/28/2010
7799816Imidazolinylmethyl aryl sulfonamide
This invention relates to an alpha-1 A receptor partial agonist, which is represented by Formula I: and pharmaceutically acceptable salts or solvates thereof. The invention further relates to pharmaceutical compositions con...
09/21/2010
7799797Arylsulfonyl naphthalene derivatives and uses thereof
Compounds of the formula I: or pharmaceutically acceptable salts thereof, wherein m, q, Ar, R1, R2 and R7 are as defined herein. Also provided are methods for preparing, compositio...
09/21/2010
7799796Diaminopyrimidines as P2Xand P2Xmodulators
Compounds and methods for treating diseases mediated by a P2X3 and/or a P2X2/3 receptor antagonist, the compounds being of formula (I): wherein D, X, R1, R2, R3, R...
09/21/2010
7786110Thiazole and oxazole-substituted arylamides as P2Xand P2Xantagonists
Compounds of the formula I: or a pharmaceutically acceptable salt thereof, wherein, R1 is a group of formula A or formula B, and X, R2, R3, R...
08/31/2010
7776872Diaminopyrimidines as P2Xand P2Xmodulators
Compounds of the formula I: or pharmaceutically acceptable salts thereof, wherein A, D, E, G, J, X, Y, Z R6, R7 and R8 are as defined herein. Also provided are methods of using the compounds...
08/17/2010
7759389Chroman derivatives and uses thereof
Compounds of the formula I: or pharmaceutically acceptable salts thereof, wherein m, p, q, Ar, R1, R2, R3 and R4 are as defined herein. Also provided are methods for pre...
07/20/2010
7754759Arylsulfonyl chromans as 5-HTinhibitors
Compounds of the formula I: wherein m, n, p, X, Ar, R1, R2, R3, R4 and R5 are as defined herein. Methods of making the compounds and using the compounds for treatment o...
07/13/2010
7754721Arylpiperazine derivatives and uses thereof
Compounds of the formula: or pharmaceutically acceptable salts thereof, wherein m, n, X, Y, Z, Ar, R1, R2, R3, R4, R5, R6 and R7 are def...
07/13/2010
7750016Hydroxyalkyl substituted pyrido-7-pyrimidin-7-ones
Compounds of the Formula: where X1, Ar1, R1, and R2 are as defined herein, and compositions comprising the same. Also provided are methods for using compounds of Formula I in trea...
07/06/2010
7741326Indole and benzofuran 2-carboxamide derivatives and uses thereof
Compounds of formula I or formula II: or pharmaceutically acceptable salts thereof, wherein m, n, p, Ar R1, R2, R4, and R5 are as defined herein. The invention also provides metho...
06/22/2010
7723391Cyclopropyl aryl amide derivatives and uses thereof
Compounds of the formula: wherein Ar1, Ar2, R1 and R2 are as defined herein. Also provided are pharmaceutical compositions, methods of using, and methods of preparing the subject ...
05/25/2010
7671235Tetralin and indane derivatives and uses thereof
Compounds of the formula I, II or III: or pharmaceutically acceptable salts thereof, wherein m, n, q, Ar, R1, R2, R3, R4 and R5 are as defined herein. Also pr...
03/02/2010
7645764Kinase inhibitors and methods for using the same
Compounds of formula I: wherein R1, R2, R3 and R4 are as defined herein. Also disclosed are methods of making the compounds, pharmaceutical compositions, methods of using the comp...
01/12/2010
76385173-Amino-1-arylpropyl azaindoles and uses thereof
The present invention provides compounds of the formula: or pharmaceutically acceptable salts, solvates or prodrugs thereof, wherein p, Ar, R1, R2, R3, Ra, Rb, Rc
12/29/2009
7622462Benzazepine derivatives and uses thereof
Compounds of the formula: or pharmaceutically acceptable salts, solvates or prodrugs thereof, wherein Ar, R1 and R2 are defined herein. Also provided are pharmaceutical compositions, methods ...
11/24/2009
1      
 
Sign InRegister
Username  
Password   
forgot password?